Current application and future perspectives of molecular typing methods to study clostridium difficile infections

Eurosurveillance

Volumn 18, Issue 4, 2013, Pages

  Knetsch, C W ^a   Lawley, T D ^b   Hensgens, M P ^a   Corver, J ^a   Wilcox, M W ^c   Kuijper, E J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^c LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR GEL ELECTROPHORESIS; ARTICLE; CAPILLARY ELECTROPHORESIS; CLOSTRIDIUM DIFFICILE INFECTION; DISEASE TRANSMISSION; HEALTH CARE ORGANIZATION; IMMUNOBLOTTING; MOLECULAR TYPING; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; RIBOTYPING; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84873808423     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/ese.18.04.20381-en     Document Type: Article

References (82)

1. Bartlett JG. Antibiotic-associated pseudomembranous colitis. Hosp Pract (Off Ed). 1981;16(12):85-8, 93-5.
2. Kelly CP, Pothoulakis C, LaMont JT. Clostridium difficile colitis. N Engl J Med. 1994;330(4):257-62.
3. Voth DE, Ballard JD. Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev. 2005;18(2):247-63.
4. Kuehne SA, Cartman ST, Heap JT, Kelly ML, Cockayne A, Minton NP. The role of toxin A and toxin B in Clostridium difficile infection. Nature. 2010;467 (7316):711-3.
5. Lyras D, O'Connor JR, Howarth PM, Sambol SP, Carter GP, Phumoonna T, et al. Toxin B is essential for virulence of Clostridium difficile. Nature. 2009;458(7242):1176-9.
6. Schwan C, Stecher B, Tzivelekidis T, van Ham M, Rohde M, Hardt WD, et al. Clostridium difficile toxin CDT induces formation of microtubule-based protrusions and increases adherence of bacteria. PLoS Pathog. 2009;5(10):e1000626.
7. Kuijper EJ, Coignard B, Tüll P; ESCMID Study Group for Clostridium difficile; EU Member States; European Centre for Disease Prevention and Control. Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect. 2006;12 Suppl 6:2-18.
8. McDonald LC, Killgore GE, Thompson A, Owens RC Jr, Kazakova SV, Sambol SP, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med. 2005;353(23):2433-41.
9. Pépin J, Valiquette L, Cossette B. Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ. 2005;173(9):1037-42.
10. Warny M, Pepin J, Fang A, Killgore G, Thompson A, Brazier J, et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet. 2005;366(9491):1079-84.
11. Goorhuis A, Bakker D, Corver J, Debast SB, Harmanus C, Notermans DW, et al. Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin Infect Dis. 2008;47(9):1162-70.
12. Cohen SH, Tang YJ, Silva J Jr. Molecular typing methods for the epidemiological identification of Clostridium difficile strains. Expert Rev Mol Diagn. 2001;1(1):61-70.
13. Delmee M, Homel M, Wauters G. Serogrouping of Clostridium difficile strains by slide agglutination. J Clin Microbiol. 1985;21(3):323-7.
14. Tabaqchali S, Holland D, O'Farrell S, Silman R. Typing scheme for Clostridium difficile: its application in clinical and epidemiological studies. Lancet. 1984;1(8383):935-8.
15. Toma S, Lesiak G, Magus M, Lo HL, Delmée M. Serotyping of Clostridium difficile. J Clin Microbiol. 1988;26(3):426-8.
16. Mulligan ME, Peterson LR, Kwok RY, Clabots CR, Gerding DN. Immunoblots and plasmid fingerprints compared with serotyping and polyacrylamide gel electrophoresis for typing Clostridium difficile. J Clin Microbiol. 1988;26(1):41-6.
17. Kuijper EJ, van den Berg RJ, Brazier JS. Comparison of molecular typing methods applied to Clostridium difficile. Methods Mol Biol. 2009;551:159-71.
18. Killgore G, Thompson A, Johnson S, Brazier J, Kuijper E, Pepin J, et al. Comparison of seven techniques for typing international epidemic strains of Clostridium difficile: restriction endonuclease analysis, pulsed-field gel electrophoresis, PCR-ribotyping, multilocus sequence typing, multilocus variable-number tandem-repeat analysis, amplified fragment length polymorphism, and surface layer protein A gene sequence typing. J Clin Microbiol. 2008;46 (2):431-7.
19. Eyre DW, Golubchik T, Gordon NC, Bowden R, Piazza P, Batty EM, et al. A pilot study of rapid benchtop sequencing of Staphylococcus aureus and Clostridium difficile for outbreak detection and surveillance. BMJ Open. 2012; 2(3).
20. Loman NJ, Misra RV, Dallman TJ, Constantinidou C, Gharbia SE, Wain J, et al. Performance comparison of benchtop high-throughput sequencing platforms. Nat Biotechnol. 2012;30(5):434-9.
21. Gürtler V. Typing of Clostridium difficile strains by PCR-amplification of variable length 16S-23S rDNA spacer regions. J Gen Microbiol. 1993;139(12):3089-97.
22. Bidet P, Barbut F, Lalande V, Burghoffer B, Petit JC. Development of a new PCR-ribotyping method for Clostridium difficile based on ribosomal RNA gene sequencing. FEMS Microbiol Lett. 1999;175(2):261-6.
23. Stubbs SL, Brazier JS, O'Neill GL, Duerden BI. PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. J Clin Microbiol. 1999;37(2):461-3.
24. van den Berg RJ, Claas EC, Oyib DH, Klaassen CH, Dijkshoorn L, Brazier JS, et al. Characterization of toxin A-negative, toxin B-positive Clostridium difficile isolates from outbreaks in different countries by amplified fragment length polymorphism and PCR ribotyping. J Clin Microbiol. 2004; 42(3):1035-41.
25. Hunter PR, Gaston MA. Numerical index of the discriminatory ability of typing systems: an application of Simpson's index of diversity. J Clin Microbiol. 1988;26(11):2465-6.
26. Kristjánsson M, Samore MH, Gerding DN, DeGirolami PC, Bettin KM, Karchmer AW, et al. Comparison of restriction endonuclease analysis, ribotyping, and pulsed-field gel electrophoresis for molecular differentiation of Clostridium difficile strains. J Clin Microbiol. 1994;32(8):1963-9.
27. Centers for Disease Control and Prevention (CDC). PulseNet. Atlanta: CDC. [Accessed 1 Jul 2012]. Available from: http://www.cdc.gov/pulsenet/
28. European Clostridium difficile infection study network (ECDIS-NET). Europe: Supporting capacity building for surveillance of Clostridium difficile. Leiden: ECDIS-NET. [Accessed 1 Jul 2012]. Available from:http://www.ecdisnet.eu/
29. Brazier JS, Delmee M, Tabaqchali S, Hill LR, Mulligan ME, Riley TV. Proposed unified nomenclature for Clostridium difficile typing. Lancet. 1994;343(8912):1578-9.
30. Lemee L, Dhalluin A, Pestel-Caron M, Lemeland JF, Pons JL. Multilocus sequence typing analysis of human and animal Clostridium difficile isolates of various toxigenic types. J Clin Microbiol. 2004;42(6):2609-17.
31. Clostridium difficile MLST Databases. Clostridium difficile Multi Locus Sequence Typing website. Oxford: University of Oxford. [Accessed 21 nov 2012]. Available from: http://pubmlst.org/cdifficile/
32. Griffiths D, Fawley W, Kachrimanidou M, Bowden R, Crook DW, Fung R, et al. Multilocus sequence typing of Clostridium difficile. J Clin Microbiol. 2010;48(3):770-8.
33. Institut Pasteur. Clostridium difficile MLST Database. Paris: Institut Pasteur. [Accessed: 1 jul 2012]. Available from: http://www.pasteur.fr/recherche/genopole/PF8/mlst/Cdifficile2.html
34. Indra A, Blaschitz M, Kernbichler S, Reischl U, Wewalka G, Allerberger F. Mechanisms behind variation in the Clostridium difficile 16S-23S rRNA intergenic spacer region. J Med Microbiol. 2010;59(Pt 11):1317-23.
35. Dingle KE, Griffiths D, Didelot X, Evans J, Vaughan A, Kachrimanidou M et al. Clinical Clostridium difficile: clonality and pathogenicity locus diversity. PLoS One. 2011; 6(5):e19993.
36. Stabler RA, Dawson LF, Valiente E, Cairns MD, Martin MJ, Donahue EH, et al. Macro and micro diversity of Clostridium difficile isolates from diverse sources and geographical locations. PLoS One. 2012;7(3):e31559.
37. Knetsch CW, Terveer EM, Lauber C, Gorbalenya AE, Harmanus C, Kuijper EJ, et al. Comparative analysis of an expanded Clostridium difficile reference strain collection reveals genetic diversity and evolution through six lineages. Infect Genet Evol. 2012;12(7):1577-85.
38. Eckert C, Vromman F, Halkovich A, Barbut F. Multilocus variable-number tandem repeat analysis: a helpful tool for subtyping French Clostridium difficile PCR ribotype 027 isolates. J Med Microbiol. 2011; 60(Pt 8):1088-94.
39. Fawley WN, Freeman J, Smith C, Harmanus C, van den Berg RJ, Kuijper EJ, et al. Use of highly discriminatory fingerprinting to analyze clusters of Clostridium difficile infection cases due to epidemic ribotype 027 strains. J Clin Microbiol. 2008;46(3):954-60.
40. Lindstedt BA. Multiple-locus variable number tandem repeats analysis for genetic fingerprinting of pathogenic bacteria. Electrophoresis. 2005;26(13):2567-82.
41. Marsh JW, O'Leary MM, Shutt KA, Pasculle AW, Johnson S, Gerding DN, et al. Multilocus variable-number tandem-repeat analysis for investigation of Clostridium difficile transmission in Hospitals. J Clin Microbiol. 2006;44(7):2558-66.
42. van den Berg RJ, Schaap I, Templeton KE, Klaassen CH, Kuijper EJ. Typing and subtyping of Clostridium difficile isolates by using multiple-locus variable-number tandem-repeat analysis. J Clin Microbiol. 2007;45(3):1024-8.
43. Broukhanski G, Low DE, Pillai DR. Modified multiple-locus variable-number tandem-repeat analysis for rapid identification and typing of Clostridium difficile during institutional outbreaks. J Clin Microbiol. 2011;49(5):1983-6.
44. Bakker D, Corver J, Harmanus C, Goorhuis A, Keessen EC, Fawley WN, et al. Relatedness of human and animal Clostridium difficile PCR Ribotype 078 isolates based on multilocus variable-number tandem-repeat analysis and tetracycline resistance. J Clin Microbiol. 2010;48(10):3744-9.
45. Goorhuis A, Debast SB, Dutilh JC, van Kinschot CM, Harmanus C, Cannegieter SC, et al. Type-specific risk factors and outcome in an outbreak with 2 different Clostridium difficile types simultaneously in 1 hospital. Clin Infect Dis. 2011;53(9):860-9.
46. Fawley WN, Wilcox MH; Clostridium difficile Ribotyping Network for England and Northern Ireland. An enhanced DNA fingerprinting service to investigate potential Clostridium difficile infection case clusters sharing the same PCR ribotype. J Clin Microbiol. 2011;49(12):4333-7.
47. Janvilisri T, Scaria J, Thompson AD, Nicholson A, Limbago BM, Arroyo LG, et al. Microarray identification of Clostridium difficile core components and divergent regions associated with host origin. J Bacteriol. 2009;191(12):3881-91.
48. Manzoor SE, Tanner HE, Marriott CL, Brazier JS, Hardy KJ, Platt S, et al. Extended multilocus variable-number tandem-repeat analysis of Clostridium difficile correlates exactly with ribotyping and enables identification of hospital transmission. J Clin Microbiol. 2011;49(10):3523-30.
49. Wei HL, Kao CW, Wei SH, Tzen JT, Chiou CS. Comparison of PCR ribotyping and multilocus variable-number tandem-repeat analysis (MLVA) for improved detection of Clostridium difficile. BMC Microbiol. 2011;11:217.
50. Indra A, Huhulescu S, Schneeweis M, Hasenberger P, Kernbichler S, Fiedler A, et al. Characterization of Clostridium difficile isolates using capillary gel electrophoresis-based PCR ribotyping. J Med Microbiol. 2008;57(Pt 11):1377-82.
51. Croucher NJ, Harris SR, Fraser C, Quail MA, Burton J, van der Linden M, et al. Rapid pneumococcal evolution in response to clinical interventions. Science. 2011;331(6016):430-4.
52. Harris SR, Feil EJ, Holden MT, Quail MA, Nickerson EK, Chantratita N, et al. Evolution of MRSA during hospital transmission and intercontinental spread. Science. 2010;327(5964):469-74.
53. Harris SR, Clarke IN, Seth-Smith HM, Solomon AW, Cutcliffe LT, Marsh P, et al. Whole-genome analysis of diverse Chlamydia trachomatis strains identifies phylogenetic relationships masked by current clinical typing. Nat Genet. 2012;44(4):413-9.
54. He M, Sebaihia M, Lawley TD, Stabler RA, Dawson LF, Martin MJ, et al. Evolutionary dynamics of Clostridium difficile over short and long time scales. Proc Natl Acad Sci U S A. 2010;107(16):7527-32.
55. Holt KE, Parkhill J, Mazzoni CJ, Roumagnac P, Weill FX, Goodhead I, et al. High-throughput sequencing provides insights into genome variation and evolution in Salmonella Typhi. Nat Genet. 2008;40(8):987-93.
56. Köser CU, Holden MT, Ellington MJ, Cartwright EJ, Brown NM, Ogilvy-Stuart AL, et al. Rapid whole-genome sequencing for investigation of a neonatal MRSA outbreak. N Engl J Med. 2012;366(24):2267-75.
57. Metzker ML. Sequencing technologies-the next generation. Nat Rev Genet. 2010;11(1):31-46.
58. Chain PS, Grafham DV, Fulton RS, Fitzgerald MG, Hostetler J, Muzny D, et al. Genomics. Genome project standards in a new era of sequencing. Science. 2009;326(5950):236-7.
59. Wellcome Trust Sanger Institute. Clostridium difficile genome data. Hinxton: Wellcome Trust Sanger Institute. [Accessed: 1 Nov 2012]. Available from: http://www.sanger.ac.uk/resources/downloads/bacteria/clostridium-difficile.html
60. Medini D, Donati C, Tettelin H, Masignani V, Rappuoli R. The microbial pan-genome. Curr Opin Genet Dev. 2005;15(6):589-94.
61. He M, Miyajima F, Roberts P, Ellison L, Pickard DJ, Martin MJ, et al. Emergence and global spread of epidemic healthcare-associated Clostridium difficile. Nat Genet. 2012;45(1):109-13.
62. Köser CU, Ellington MJ, Cartwright EJ, Gillespie SH, Brown NM, Farrington M, et al. Routine use of microbial whole genome sequencing in diagnostic and public health microbiology. PLoS Pathog. 2012;8(8):e1002824.
63. van Belkum A, Tassios PT, Dijkshoorn L, Haeggman S, Cookson B, Fry NK, et al. Guidelines for the validation and application of typing methods for use in bacterial epidemiology. Clin Microbiol Infect. 2007;13 Suppl 3:1-46.
64. Pépin J, Saheb N, Coulombe MA, Alary ME, Corriveau MP, Authier S, et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis. 2005;41(9):1254-60.
65. Hensgens MP, Keessen EC, Squire MM, Riley TV, Koene MG, de Boer E, et al. Clostridium difficile infection in the community: a zoonotic disease? Clin Microbiol Infect. 2012;18(7):635-45.
66. Jhung MA, Thompson AD, Killgore GE, Zukowski WE, Songer G, Warny M, et al. Toxinotype V Clostridium difficile in humans and food animals. Emerg Infect Dis. 2008;14(7):1039-45.
67. Keessen EC, Gaastra W, Lipman LJ. Clostridium difficile infection in humans and animals, differences and similarities. Vet Microbiol. 2011;153(3-4):205-17.
68. Koene MG, Mevius D, Wagenaar JA, Harmanus C, Hensgens MP, Meetsma AM, et al. Clostridium difficile in Dutch animals: their presence, characteristics and similarities with human isolates. Clin Microbiol Infect. 2012;18(8):778-84.
69. de Boer E, Zwartkruis-Nahuis A, Heuvelink AE, Harmanus C, Kuijper EJ. Prevalence of Clostridium difficile in retailed meat in the Netherlands. Int J Food Microbiol. 2011. 144(3):561-4.
70. Asensio A, Vaque-Rafart J, Calbo-Torrecillas F, Gestal-Otero JJ, Lopez-Fernandez F, Trilla-Garcia A, et al. Increasing rates in Clostridium difficile infection (CDI) among hospitalised patients, Spain 1999-2007. Euro Surveill. 2008;13(31):pii=18943. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=18943
71. Birgand G, Blanckaert K, Carbonne A, Coignard B, Barbut F, Eckert C, et al. Investigation of a large outbreak of Clostridium difficile PCR-ribotype 027 infections in northern France, 2006-2007 and associated clusters in 2008-2009. Euro Surveill. 2010;15(25):pii=19597. Available from:http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19597
72. Indra A, Huhulescu S, Fiedler A, Kernbichler S, Blaschitz M, Allerberger F. Outbreak of Clostridium difficile 027 infection in Vienna, Austria 2008-2009. Euro Surveill. 2009;14(17):pii=19186. Available from:http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19186
73. Ingebretsen A, Hansen G, Harmanus C, Kuijper EJ. First confirmed cases of Clostridium difficile PCR ribotype 027 in Norway. Euro Surveill. 2008;13(2):pii=8011. Available from:http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=8011
74. Kleinkauf N, Weiss B, Jansen A, Eckmanns T, Bornhofen B, Küehnen E, et al. Confirmed cases and report of clusters of severe infections due to Clostridium difficile PCR ribotype 027 in Germany. Euro Surveill. 2007;12(46):pii=3307. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=3307
75. Kotila SM, Virolainen A, Snellman M, Ibrahem S, Jalava J, Lyytikäinen O. Incidence, case fatality and genotypes causing Clostridium difficile infections, Finland, 2008. Clin Microbiol Infect. 2011;17(6):888-93.
76. Suetens C. Clostridium difficile: summary of actions in the European Union. Euro Surveill. 2008;13(31):pii=18944. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=18944
77. Terhes G, Urbán E, Konkoly-Thege M, Székely E, Brazier JS, Kuijper EJ, et al. First isolation of Clostridium difficile PCR ribotype 027 from a patient with severe persistent diarrhoea in Hungary. Clin Microbiol Infect. 2009;15(9):885-6.
78. Viseur N, Lambert M, Delmee M, Van Broeck J, Catry B (2011) Nosocomial and non-nosocomial Clostridium difficile infections in hospitalised patients in Belgium-compulsory surveillance data from 2008 to 2010. Euro Surveill. 16(43):pii=20000. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20000
79. Wilcox MH, Shetty N, Fawley WN, Shemko M, Coen P, Birtles A, et al. Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping based surveillance scheme in England. Clin Infect Dis. 2012;55(8):1056-63.
80. Bauer MP, Notermans DW, van Benthem BH, Brazier JS, Wilcox MH, Rupnik M, et al. Clostridium difficile infection in Europe: a hospital-based survey. Lancet. 2011;377(9759):63-73.
81. Hensgens MP, Goorhuis A, Notermans DW, van Benthem BH, Kuijper EJ. Decrease of hypervirulent Clostridium difficile PCR ribotype 027 in the Netherlands. Euro Surveill. 2009;14(45):pii=19402. Available from:http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19402
82. Office for National Statistics (ONS). Deaths Involving Clostridium Difficile-England and Wales, 2006 to 2010. Newport: ONS. [Accessed: 1 Jul 2012]. Available from: http://www.ons.gov.uk/ons/rel/subnational-health2/deaths-involving-clostridium-difficile/2006-to-2010/statistical-bulletin.html